Kaneh Bosm Expands European Cannabis Footprint with Danish Cultivation and Manufacturing Licence
(firmenpresse) - Kaneh Bosm Expands European Cannabis Footprint with Danish Cultivation and Manufacturing Licence
VANCOUVER, British Columbia, August 28, 2018 -- Kaneh Bosm BioTechnolgy Inc. (CSE: KBB)(FWB: 8K51)(OTC: KNHBF)(Kaneh Bosm or the Company) is pleased to announce that it has entered into a definitive agreement (the Agreement) with Danavian Cannabis Ltd. (Danavian) to acquire 100% of Danavians issued and outstanding shares.
Danavian controls licenses for cannabis cultivation and manufacturing in the Kingdom of Denmark. Kaneh Bosms entry into Denmark mirrors industry peers such as Canopy Growth Corporation, Green Organic Dutchman Holdings, Aurora Cannabis Inc. and CannTrust Holdings.
Danavian has engaged an Israeli cannabis organic cultivation and management company, Sababa Sciences Inc. (Sababa Sciences). Sababa Sciences will provide end-to-end management including the implementation of advanced Israeli agricultural technologies for high quality medical cannabis treatments. Danavian and Sababa Sciences have designed a 55,000 square foot, fully automated greenhouse facility that will meet IMC-GAP, ISO:9001 and European GMP standards. Finished cannabis and cannabis derivatives produced by Danavian will be sold through Denmarks retail pharmacy network.
On January 1, 2018, Denmark legalized medical cannabis following a unanimous vote by the Danish parliament. Since legalization, the Danish government has displayed strong support for cannabis development, in the forms of research grants and tax incentives.
Danavian holds claim to premier European cannabis assets; domiciled in a jurisdiction with a highly skilled agriculture and manufacturing workforce. Davavian also boasts various industry relationships that will complement future development potential throughout Scandinavia. Continued development of Danavians Danish cannabis portfolio will help serve both local and export market demand. Danavian is tactically positioned in immediate proximity to Germany, allowing for direct imports of CBD products, as well as medical cannabis flower.
Eugene Beukman, Chief Executive Officer of Kaneh Bosm states, Kaneh Bosm now holds claim to one of twelve highly coveted Danish cannabis cultivation and manufacturing licences. Denmark has proven to be an environment conducive to the continued development of sustainable and forward thinking cannabis enterprises. The Company looks forward to capitalizing on Denmarks tactical position within the European Union and well funded healthcare system.
The acquisition of Danavian will create material synergises with Kaneh Bosms existing European distribution channels and cultivation capabilities. This Agreement further enhances the Companys vertically integrated, European seed-to-sale aspirations. Danavian and Sababa Sciences plan to apply for local approvals to manufacture and distribute Sababas patented, formulated products.
Under the terms of the Agreement, the Company will issue approximately 37,878,787 common shares of the Company and pay a cash fee of $2,944,820.
The Company also announces it has elected not to conclude its previously announced transaction in Slovenia.
On behalf of the Board of Directors of Kaneh Bosm Biotechnology Inc.
Michael Martinz
Michael Martinz
President, Director
mmartinz(at)kanehbosmbiotech.com
Kaneh Bosm BioTechnology Inc.
810 - 789 West Pender Street
Vancouver BC V6C 1H2
Tel: 604.687.2308
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
This news release includes certain statements that may be deemed forward-looking statements. The use of any of the words anticipate, continue, estimate, expect, may, will, would, project, should, believe and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Companys disclosure documents which can be found under the Companys profile on www.sedar.com
Leseranfragen:
" alt="Montego Resources Hires SRK Consulting to Expand Mineralization Zones and Update Current Resource Statement
Datum: 28.08.2018 - 09:06 Uhr
Sprache: Deutsch
News-ID 580059
Anzahl Zeichen: 4808
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 198 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kaneh Bosm Expands European Cannabis Footprint with Danish Cultivation and Manufacturing Licence
"
steht unter der journalistisch-redaktionellen Verantwortung von
Kaneh Bosm BioTechnology Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
